First-In-Human, Phase Ia/B, Dose-Escalation/Expansion Study Of Kras G12C Inhibitor Bi 1823911, As Monotherapy And Combined With Anticancer Therapies, In Patients (Pts) With Advanced Or Metastatic Solid Tumours Harbouring A Kras G12C Mutation
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: First-In-Human, Phase Ia/B, Dose-Escalation/Expansion Study Of Kras G12C Inhibitor Bi 1823911, As Monotherapy And Combined With Anticancer Therapies, In Patients (Pts) With Advanced Or Metastatic Solid Tumours Harbouring A Kras G12C Mutation ### Output: 